š¬ Current Disease Focus:
Task Progress: 0%
š„ Active Problem Solvers
0
š Experts collaborating globally
ā” Current Task Assignment
š§¬ Genetic Analysis
š Matching experts to specific tasks
š Resource Allocation by Research Phase:
š Data Analysis
š§Ŗ Experimental Design
š¬ Clinical Trials
š Treatment Development
This study is divided into 5 arms: 1. Randomized Clinical Trial (RCT): Pro...
Status
Completed
Location
Baptist Medical Center Princeton
Start Date
2005-06
Trial ID
NCT00180479
XIENCE VĀ® India is a prospective, open-label, multi-center, observational, ...
Status
Completed
Location
CARE Hospital
Start Date
2008-06
Trial ID
NCT00631228
Treatments Being Tested
The target enrollment goal for the trial was to enroll 36 subjects. However...
Status
Terminated
Location
Austin Health
Start Date
2011-11
Trial ID
NCT01308346
The purpose of this two part study is the assessment of the performance of ...
Status
Completed
Location
A.O. San Giovanni di Dio
Start Date
2007-09
Trial ID
NCT00531011
XIENCE V USA is a prospective, multi-center, multi-cohort postapproval stud...
Status
Completed
Location
Birmingham Heart Clinic, PC
Start Date
2009-08
Trial ID
NCT01106534
The purpose of this two part study is the assessment of the performance of ...
Status
Completed
Location
A.O. San Giovanni di Dio
Start Date
2007-09
Trial ID
NCT01310309
Treatments Being Tested
To establish the safety and efficacy of the commercially approved XIENCE Fa...
Status
Completed
Location
Abbott Vascular
Start Date
2010-09-29
Trial ID
NCT01205776
Treatments Being Tested
The purpose of this Clinical Evaluation is a continuation in the assessment...
Status
Completed
Location
Salzburger Landeskliniken
Start Date
2006-11
Trial ID
NCT01171820
Treatments Being Tested
This trial is to assess physician-determined XIENCE VĀ® EECSS acute performa...
Status
Completed
Location
The Heart Center, PC
Start Date
2008-10
Trial ID
NCT00731237
XIENCE V USA is a prospective, multi-center, multi-cohort post-approval stu...
Status
Completed
Location
Abbott Vascular
Start Date
2008-07
Trial ID
NCT01120379
Treatments Being Tested